General Western Blot Reagents
Abcam gamma-Tocotrienol, Form of vitamin E, 5MG
MW 410.6 Da, Purity >98%. Form of vitamin E. Antioxidant agent. Tocotrienol α (ab144451), β (ab145176) and δ (ab144449) analog. Induces apoptosis in cancer cells. Shows antitumor and antihypertensive effects in vivo. Orally active.
The product is subject to the following: Abcam Restricted Use Statement
Abcam delta-Tocotrienol, Form of vitamin E, 10MG
MW 396.6 Da, Purity >98%. Form of vitamin E. Lipophilic antioxidant agent. Tocotrienol α (ab144451), β (ab145176), and γ (ab144448) analog. Induces apoptosis in cancer cells. Enhances bone formation, shows antitumor, neuroprotective and antioxidant effects in vivo. Orally active.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Mouse C1QA peptide, 1MG
Mouse C1QA peptide is a Synthetic blocking peptide. >70% purity and suitable for BL.
Protein/ Peptide/ Enzyme Synonyms: Complement C1q subcomponent subunit A, C1qa
Conjugation: Unconjugated
The product is subject to the following: Abcam Restricted Use Statement
Abcam Complex II Immunocapture Kit.
Complex II Immunocapture Kit.
The product is subject to the following: Abcam Restricted Use Statement
Abcam KDM1/LSD1 Activity Quantification Assay Kit (Fluorometric).
KDM1/LSD1 Activity Quantification Assay Kit (Fluorometric).
The product is subject to the following: Abcam Restricted Use Statement
Abcam KDM1/LSD1 Activity Quantification Assay Kit (Fluorometric).
KDM1/LSD1 Activity Quantification Assay Kit (Fluorometric).
The product is subject to the following: Abcam Restricted Use Statement
Abcam KDM5/JARID Activity Quantification Assay Kit (Colorimetric).
KDM5/JARID Activity Quantification Assay Kit (Colorimetric).
The product is subject to the following: Abcam Restricted Use Statement
Abcam KDM5/JARID Activity Quantification Assay Kit (Fluorometric).
KDM5/JARID Activity Quantification Assay Kit (Fluorometric).
The product is subject to the following: Abcam Restricted Use Statement
Abcam BRD-7389, p90 ribosomal S6 kinase RSK inhibitor, 25MG
MW 366.4 Da. p90 ribosomal S6 kinase RSK inhibitor (IC₅₀ values are 1.2, 1.5 and 2.4 μM for RSK3, RSK1 and RSK2 respectively). Upregulates insulin expression in pancreatic α-cells. Shows reprogramming effects in terminally differentiated cells.
The product is subject to the following: Abcam Restricted Use Statement
Abcam LM11A-31, nonpeptide p75NTR ligand, 5MG
MW 316.26 Da. Selective nonpeptide p75NTR ligand. Blocks p75-mediated cell death. Promotes neurogenesis and neurite survival. Does not affect NGF binding to TrkA. Shows neuroprotective and neuroregenerative effects *in vivo.* Orally active. Blood-brain barrier permeable.
The product is subject to the following: Abcam Restricted Use Statement
Abcam 4-Aminophenyl phosphate monosodium salt, Alkaline phosphatase substrate, 10MG
MW 211.09 Da, Purity >99%. Substrate for electrochemical alkaline phosphatase measurement. Achieve your results faster with highly validated, pure and trusted compounds.
The product is subject to the following: Abcam Restricted Use Statement
Abcam ML-9, protein kinase inhibitor, 250MG
MW 361.3 Da, Purity >98%. Broad spectrum ATP-competitive protein kinase inhibitor (Ki values are 32, 4, and 54 μM for PKA, MLCK, and PKC respectively). Ca²+ channel blocker. Shows vasorelaxant effects in vivo. .
The product is subject to the following: Abcam Restricted Use Statement
Abcam PBFI AM, fluorescent K+ binding probe, 1MG
MW 1171.1 Da, Purity >94%. Cell-permeable, fluorescent K+ binding probe (Kd = 5 mM). Active *in vitro*. Non-specific esterases hydrolyze the AM esters to produce the water-soluble form of PBFI.Excitation is 340/390 nm.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Factor XIa Assay Kit
Factor XIa Assay Kit
The product is subject to the following: Abcam Restricted Use Statement